arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Annovis Bio, Inc.

ANVS

$0.66 ▼ -0.54 (-44.88%) at close

31 Visible periods

20 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Annovis Bio, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $24.8M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 267.0% ↗

FCF / Share $-0.58 ↘

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

31-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-17.61M

↓ -218.0% —

FCF / Share Free cash flow per share

$-0.58

↓ -80.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Dec 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
EPS Growth YoY (%)	-25.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-96.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-2.6% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	61.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	27.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-220.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	83.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	40.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	58.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	91.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-147.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-106.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-46.6% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-65.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-25.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-125.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	-188.5% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-218.0% Weak ↑ Weak Improving Year-over-year change in net income	-218.0% Weak ↑ Weak Improving Year-over-year change in net income	-67.7% Weak ↑ Weak Improving Year-over-year change in net income	-419.0% Weak ↓ Weak Declining Year-over-year change in net income	-419.0% Weak ↓ Weak Declining Year-over-year change in net income	-419.0% Weak ↓ Weak Declining Year-over-year change in net income	73.6% Excellent ↓ Excellent Declining Year-over-year change in net income	89.0% Excellent ↑ Excellent Improving Year-over-year change in net income	89.0% Excellent ↑ Excellent Improving Year-over-year change in net income	89.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-187.5% Weak ↓ Weak Declining Year-over-year change in net income	-86.0% Weak ↓ Weak Declining Year-over-year change in net income	-86.0% Weak ↓ Weak Declining Year-over-year change in net income	-65.2% Weak ↓ Weak Declining Year-over-year change in net income	-30.6% Weak ↑ Weak Improving Year-over-year change in net income	-63.6% Weak ↑ Weak Improving Year-over-year change in net income	-63.6% Weak ↑ Weak Improving Year-over-year change in net income	-84.2% Weak ↑ Weak Improving Year-over-year change in net income	-247.0% Weak ↑ Weak Improving Year-over-year change in net income	-624.6% Weak ↑ Weak Improving Year-over-year change in net income	-624.6% Weak ↓ Weak Declining Year-over-year change in net income	-624.6% Weak ↓ Weak Declining Year-over-year change in net income	-747.0% Weak ↓ Weak Declining Year-over-year change in net income	-131.3% Weak → Weak Stable Year-over-year change in net income	-131.3% Weak Weak Year-over-year change in net income	-131.3% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	30.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	29.8% Excellent Excellent Year-over-year change in free cash flow	—	—	—	53.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-283.0% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Dec 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
FCF / Net Income (x)	1.24x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.46x Good Good Free cash flow relative to reported net income Optimal: > 1x	1.41x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	6.59x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.42x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.19x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.28x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.30x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.45x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	2.20x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.26x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.23x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.20x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Dec 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	267.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-455.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-45.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-44.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-57.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-62.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	443.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	232.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	106.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-223.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-47.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-49.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-21.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-73.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	8.0% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	2.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	3.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	2.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-65.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-110.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-46.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-48.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-30.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-153.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-100.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-102.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-145.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-42.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-39.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-54.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-5.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-78.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	—	—	-58.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-489%)	-42.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-381%)	-30.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-301%)	-23.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-253%)	-63.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-520%)	-15.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-201%)	60.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+306%)	31.8% Excellent → Excellent Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+112%)	286.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1811%)	-146.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1075%)	-46.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-413%)	-48.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-422%)	-27.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-282%)	-15.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-201%)	-13.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-190%)	-14.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-193%)	-13.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-189%)	-6.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	-6.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-144%)	-73.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-588%)	-22.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-251%)	-4.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-132%)	-4.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-131%)	-4.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-128%)	2.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-84%)	2.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-85%)	2.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-84%)	2.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-84%)	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Dec 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Net Debt (USD)	$-18.73M	$-14.22M	$-19.53M	$-15.29M	$-17.13M	$-22.24M	$-10.55M	$-12.64M	$-4.00M	$-3.14M	$-5.75M	$-6.35M	$-15.72M	$-16.76M	$-28.38M	$-31.99M	$-35.97M	$-42.67M	$-45.69M	$-47.46M	$-49.22M	$-5.60M	$-8.07M	$-8.84M	$-9.76M	$-11.12M	$-1.86K	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Dec 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	—	—	$0.00	—	$0.00	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.40	$-0.63	$-0.39	$-0.37	$-0.32	$-0.32	$-0.38	$-0.97	$-0.44	$-0.10	$-2.33	$-1.63	$-1.07	$-1.19	$-0.94	$-0.79	$-0.73	$-0.72	$-0.75	$-0.35	—	—	$-0.26	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.58	$-0.32	—	$-0.18	—	$-0.46	—	—	—	$-0.66	—	—	—	$-1.42	—	$-0.49	$-0.82	$-0.37	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-0.10	$0.11	$0.62	$0.65	$0.94	$1.23	$0.66	$0.53	$-0.15	$-0.30	$-0.74	$0.74	$2.30	$2.45	$3.47	$4.24	$4.74	$5.15	$5.49	$5.74	$6.01	$0.63	$1.09	$1.33	$1.38	$1.56	$-30.35	—	—	—	—
Tangible Book Value per Share (USD)	$-0.10	$0.11	$0.62	$0.65	$0.94	$1.23	$0.66	$0.53	$-0.15	$-0.30	$-0.74	$0.74	$2.30	$2.45	$3.47	$4.24	$4.74	$5.15	$5.49	$5.74	$6.01	$0.63	$1.09	$1.33	$1.38	$1.56	$-30.35	—	—	—	—
Basic Weighted Avg Shares (shares)	37.52M	27.85M	—	19.69M	19.49M	17.43M	—	12.98M	11.31M	10.63M	—	9.01M	8.95M	8.19M	—	8.16M	8.16M	8.16M	—	8.10M	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Dec 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	—	—	—	—	—	—	—	—	—	$2.94M	—	$6.66M	$20.74M	$20.14M	$28.32M	$34.59M	$38.67M	$42.04M	$44.49M	$46.53M	$48.61M	$4.37M	$7.54M	$9.12M	$9.50M	$10.69M	$-1.26M	—	—	—	—
Total Equity (USD)	$-4.25M	$3.13M	$16.85M	$13.16M	$18.33M	$24.05M	$9.31M	$7.06M	$-1.75M	$-3.35M	$-7.75M	$6.66M	$20.74M	$20.14M	$28.32M	$34.59M	$38.67M	$42.04M	$44.49M	$46.53M	$48.61M	$4.37M	$7.54M	$9.12M	$9.50M	$10.69M	$-8.58M	$-8.37M	$-8.12M	$-7.78M	$-7.59M

📋 What is driving earnings? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Dec 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	—	—	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	—	—	$0.00	—
Net Income, GAAP (USD)	$-17.61M	$-17.61M	$-9.83M	$-5.54M	$-5.54M	$-5.54M	$-5.86M	$-1.07M	$-1.07M	$-1.07M	$-22.21M	$-9.74M	$-9.74M	$-9.74M	$-7.73M	$-5.23M	$-5.23M	$-5.89M	$-5.91M	$-3.20M	$-3.20M	$-3.20M	$-1.70M	$-441.59K	$-441.59K	$-441.59K	$-201.26K	$-190.90K	$-190.90K	$-190.90K	—
Operating Cash Flow (USD)	$-21.91M	$-9.01M	$-8.93M	$-3.49M	—	$-8.10M	$-8.29M	—	—	$-7.03M	$-9.36M	—	—	$-11.63M	$-3.61M	$-3.99M	$-6.69M	$-3.02M	$-1.77M	—	—	$-2.47M	$-765.95K	—	—	$-970.40K	$-52.53K	$-44.68K	$-150.59K	$-228.74K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 8 years · 31 quarters

Annovis Bio, Inc.

Analytical Summary

31-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ANVS with peers